Increasing Prevalence Of Chronic Disorders With Growing Awareness Of Early Diagnosis Is Positively Influencing The Demand For Endoscopes
“Increasing cases of gastrointestinal disorders and obesity is driving the demand for endoscopes in the healthcare sector.” states a Fact.MR analyst
Fact.MR, a market research and competitive intelligence provider: The global sales of endoscopes is expected to surpass US$ 34 Bn by registering a staggering double digit CAGR of 10% in the forecast period 2022-2032. Growing prevalence of gastrointestinal disorders along with awareness of benefits of early diagnosis is increasing the demand for endoscopes.
Historically, from 2015 to 2021, the global sales of endoscopes flourished at a CAGR of 9%. The onset of COVID-19 pandemic affected the demand for endoscopes due to the fear of transmission of virus. As most diagnosis take place at the hospitals, patients did not prefer to get diagnosed. With the world getting back to normalcy, the demand for endoscopes is expected to escalate.
Furthermore, obesity is a key driving factor for the rising demand for endoscopes. As the obesity rate is increasing rapidly, people suffering from obesity are giving preference to gastroplasty procedures. Moreover, cost effectiveness and safety are driving the demand for endoscopes.
For more insights into the Market, Get A Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=7118
Key Takeaways from Market Study
For Comprehensive Insights Ask An Analyst Here https://www.factmr.com/connectus/sample?flag=AE&rep_id=7118
The high burden of cancer and functional gastrointestinal disorders in the U.S. is expected to drive the demand for endoscopes. Increasing number of people suffering from gastrointestinal disorders in China and India is propelling the demand for endoscopes. Moreover, growing geriatric population and improving healthcare infrastructure is positively influencing the demand for endoscopes in the region.
Furthermore, the presence of key players in Asia Pacific is bolstering the adoption of endoscopes. Thus, Asia Pacific is expected to hold more than 35% market share for endoscopes.
Key Segments Covered in the Endoscopes Market Report
Get Customization on this Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=7118
Fact.MR, in its new offering, presents an unbiased analysis of the global automotive steering system market, presenting historical demand data (2015-2021) and forecast statistics for the period of 2022-2032.
The study indulges essential insights on the market on the basis of product type (rigid endoscopes and flexible endoscopes), application (Laparoscopy, Otoscopy, Laryngoscopy, Urology Endoscopy (Cystoscopy), Bronchoscopy, Gastrointestinal (GI) Endoscopy, Obstetrics/Gynecology Endoscopy, Arthroscopy, Mediastinoscopy, Other Applications), end use (Ambulatory Surgery Centers/Clinics, Hospitals, Other End Uses) and across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).
Fact.MR’s Domain Knowledge in Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Check out more studies related to Healthcare Industry, conducted by Fact.MR:
Self-Administered Medication Market - The global self-administered medication market is estimated at USD 87.5 Billion in 2022 and is forecast to surpass USD 200.5 Billion by 2032, growing at a CAGR of 8.6% from 2022 to 2032.
Tissue Expanders Market - The global tissue expanders market is projected to account for ~1% of the global cosmetics surgery market in 2022. The global tissue expanders market is estimated to have an absolute $ opportunity of USD 664.7 Million during the forecast years of 2022-2032.
Non-Invasive Aesthetic Treatment Market - The growing interest in adult appearance has led to increased demand for non-invasive aesthetic treatments. Injectables are expected to be the highest revenue-generating segment, accounting for an absolute dollar opportunity of nearly US$ 149.7 Bn during 2022 – 2032.
Sacroiliac Joint Fusion Market - The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.
Cardiac Resynchronization Therapy Market - The increasing prevalence of diseases is driving the market's growth (primarily due to the rising geriatric population). Rising investments and support, as well as technology improvements, are all helping to drive this market forward.
Laboratory Information Management System Market - The Laboratory Information Management System market reached a valuation of US$ 1.8 Bn in 2021 with an increase of 7.5% over the last year. The worldwide revenues are projected to increase by 2x in 2032.
Home Infusion Therapy Market - With 8.6%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Bn during 2022 – 2032.
Omics Based Clinical Trials Market - Omics-Based Clinical Trials Market was valued at US$ 26.2 Bn in 2021. Covid 19 emerged as a turning point for Omics Based Clinical Trials Market and it grew at a 7.5% annual pace compared to the previous year 2020
Blood Ketone Meter Market - Global sales of Blood Ketone Meter in 2021 was held at US$ 275.1 Mn. With 8.1%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.
Skincare Devices Market - Sales of skincare devices were valued at US$ 12 Bn in 2021, and are expected to gather momentum, reaching US$ 14 Bn by the end of 2022. Furthermore, the market is forecast to expand 3.1x to be valued at US$ 43.48 Bn in 2032.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
© 1985 - 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software